Clinical and laboratory features of the most common Clostridium difficile ribotypes isolated in Belgium.

[1]  C. Janoir.  Virulence factors of Clostridium difficile and their role during infection. , 2016, Anaerobe.

[2]  K. Garey,et al.  In the Endemic Setting, Clostridium difficile Ribotype 027 Is Virulent But Not Hypervirulent , 2015, Infection Control & Hospital Epidemiology.

[3]  D. Aronoff,et al.  The relationship between phenotype, ribotype, and clinical disease in human Clostridium difficile isolates. , 2013, Anaerobe.

[4]  J. Perry,et al.  Effect of ribotype on all-cause mortality following Clostridium difficile infection. , 2013, The Journal of hospital infection.

[5]  T. Peto,et al.  Relationship Between Bacterial Strain Type, Host Biomarkers, and Mortality in Clostridium difficile Infection , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  E. Kuijper,et al.  Clostridium difficile: a European perspective. , 2013, The Journal of infection.

[7]  T. Riley,et al.  Epidemiology of Clostridium difficile infection in , 2013 .

[8]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[9]  L. Valiquette,et al.  Prediction Tools for Unfavourable Outcomes in Clostridium difficile Infection: A Systematic Review , 2012, PloS one.

[10]  J. Hegarty,et al.  Predicting Recurrence of C. difficile Colitis Using Bacterial Virulence Factors: Binary Toxin Is the Key , 2012, Journal of Gastrointestinal Surgery.

[11]  I. Poxton,et al.  Comparison of toxin and spore production in clinically relevant strains of Clostridium difficile. , 2011, Microbiology.

[12]  Mark A. Miller,et al.  Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  A. Guyot,et al.  Clostridium difficile ribotypes 027 and 106: clinical outcomes and risk factors. , 2009, The Journal of hospital infection.

[14]  J. Corver,et al.  Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  T. Åkerlund,et al.  Correlation of Disease Severity with Fecal Toxin Levels in Patients with Clostridium difficile-Associated Diarrhea and Distribution of PCR Ribotypes and Toxin Yields In Vitro of Corresponding Isolates , 2006, Journal of Clinical Microbiology.

[16]  P. Bidet,et al.  Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing. , 1999, FEMS microbiology letters.

[17]  J. Brazier,et al.  Modification of a PCR Ribotyping Method for Application as a Routine Typing Scheme forClostridium difficile , 1996 .